Page last updated: 2024-09-04

moxifloxacin and Retinal Detachment

moxifloxacin has been researched along with Retinal Detachment in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Alami, A; Bjerre, LM; Gravel, CA; Krewski, D; Mattison, D; Momoli, F; Taher, MK; Tsui, D1
Eguchi, H; Hotta, F; Kusujima, K; Kuwahara, T; Mitamura, Y; Naito, T1

Other Studies

2 other study(ies) available for moxifloxacin and Retinal Detachment

ArticleYear
Systemic quinolones and risk of retinal detachment I: analysis of data from the US FDA adverse event reporting system.
    Expert opinion on drug safety, 2022, Volume: 21, Issue:2

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Female; Humans; Infant; Male; Middle Aged; Moxifloxacin; Pharmacoepidemiology; Pharmacovigilance; Quinolones; Retinal Detachment; Risk; Sensitivity and Specificity; United States; United States Food and Drug Administration; Young Adult

2022
Achromobacter buckle infection diagnosed by a 16S rDNA clone library analysis: a case report.
    BMC ophthalmology, 2014, Nov-24, Volume: 14

    Topics: Achromobacter; Anti-Bacterial Agents; Betamethasone; Cefdinir; Cephalosporins; Device Removal; DNA, Bacterial; DNA, Ribosomal; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Gram-Negative Bacterial Infections; Humans; Middle Aged; Moxifloxacin; Polymerase Chain Reaction; Prosthesis-Related Infections; Retinal Detachment; RNA, Ribosomal, 16S; Scleral Buckling

2014